Lee Han Hee, Kim Dong Hyun, Lim Hyun, Kim Jung-Wook, Jung Yunho, Kim Hyun-Soo, Oh Hyung-Hoon, Kim Jin Won, Cho Kwang Bum, Joo Young-Eun, Lee Bo-In
Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
Research Group for Stent in the Korean Society of Gastrointestinal Endoscopy, Seoul, Republic of Korea.
Surg Endosc. 2025 Mar;39(3):1544-1554. doi: 10.1007/s00464-024-11424-3. Epub 2025 Jan 3.
Self-expandable metal stents (SEMS) are effective in alleviating malignant colorectal obstruction. However, bowel perforation following SEMS placement remains a significant concern, as it can adversely affect oncological outcomes. This study aimed to evaluate the recurrence and overall survival rates associated with SEMS-related bowel perforations.
This multicenter, retrospective analysis included patients with obstructive colorectal cancer who underwent SEMS placement as a bridge to surgery. The data collection period spanned from January 2008 to May 2019, with patient matching in a 1:5 ratio based on age, sex, tumor location, pathological stage, and achievement of curative resection.
Among the 412 patients who received SEMS placement, 25 (6.1%) patients experienced SEMS-related perforations (perforation group), with 21 instances classified as overt and four as silent perforations. Compared with 125 matched controls (non-perforation group), the perforation group showed elevated rates of emergent surgery, open surgery, and stoma formation, as well as a reduced interval from SEMS placement to surgery. The 5-year recurrence rate was notably higher in the perforation group than in the no-perforation group (47.4% vs. 21.5%, p < 0.001), whereas the 5-year survival rate was not significantly different between groups (63.8% vs. 80.0%, p = 0.330).
SEMS-related perforation led to less favorable surgical outcomes and a higher rate of recurrence, although no notable impact on overall survival was observed. Considering the risk of perforation, these findings support the cautious use of SEMS as a bridge to surgery.
自膨式金属支架(SEMS)在缓解结直肠癌恶性梗阻方面有效。然而,SEMS置入后肠穿孔仍是一个重大问题,因为它会对肿瘤学结局产生不利影响。本研究旨在评估与SEMS相关肠穿孔相关的复发率和总生存率。
这项多中心回顾性分析纳入了因结直肠癌梗阻而接受SEMS置入作为手术过渡的患者。数据收集期为2008年1月至2019年5月,根据年龄、性别、肿瘤位置、病理分期和根治性切除的完成情况,以1:5的比例对患者进行匹配。
在412例接受SEMS置入的患者中,25例(6.1%)发生了与SEMS相关的穿孔(穿孔组),其中21例为显性穿孔,4例为隐性穿孔。与125例匹配的对照组(非穿孔组)相比,穿孔组的急诊手术、开放手术和造口形成率更高,且从SEMS置入到手术的间隔时间更短。穿孔组的5年复发率显著高于非穿孔组(47.4%对21.5%,p<0.001),而两组的5年生存率无显著差异(63.8%对80.0%,p=0.330)。
尽管未观察到对总生存有显著影响,但SEMS相关穿孔导致手术结局较差且复发率较高。考虑到穿孔风险,这些发现支持谨慎使用SEMS作为手术过渡手段。